Consainsights logo
Reports / Next Generation Diabetes Therapy and Drug Delivery Market

Next Generation Diabetes Therapy and Drug Delivery Market

Next Generation Diabetes Therapy and Drug Delivery Market Research Report – Segmented By Demographics (ADULT POPULATION (>14YEARS), CHILD POPULATION (≤14YEARS)), Indication (TYPE I DIABETES, TYPE II DIABETES), End User (DIAGNOSTICS/CLINICS, HOME HEALTHCARE, ICUS) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Next Generation Diabetes Therapy and Drug Delivery Market was valued at US $29.14 billion in 2021 and is projected to grow at 9.15% CAGR over the forecast period to reach US $49.28 billion by 2027. Next Generation Diabetes Therapy and Drug Delivery Market represented US $4.68 billion opportunity over 2019-2021 and estimated to create US $20.14 billion opportunity in 2027 over 2021.

Next Generation Diabetes Therapy and Drug Delivery from Consainsights analyses the Next Generation Diabetes Therapy and Drug Delivery Market in the Life Sciences industry over the forecast period to 2027.

Next Generation Diabetes Therapy and Drug Delivery research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Next Generation Diabetes Therapy and Drug Delivery segmentation includes Demographics, Indication, End User and Geography.

Based on the Demographics, the Next Generation Diabetes Therapy and Drug Delivery analysis covers ADULT POPULATION (>14YEARS), CHILD POPULATION (≤14YEARS).

In Demographics segment, ADULT POPULATION (>14YEARS) segment has highest cagr growth of 8.09%.

Based on the Indication, the Next Generation Diabetes Therapy and Drug Delivery analysis covers TYPE I DIABETES, TYPE II DIABETES.

In Indication segment, TYPE I DIABETES segment has highest cagr growth of 8.09%.

Based on the End User, the Next Generation Diabetes Therapy and Drug Delivery analysis covers DIAGNOSTICS/CLINICS, ICUS, HOME HEALTHCARE.

In End User segment, DIAGNOSTICS/CLINICS segment has highest cagr growth of 8.09%.

Based on the region, the Next Generation Diabetes Therapy and Drug Delivery analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include ABBOTT LABORATORIES, DEXCOM, INC., ECHO THERAPEUTICS, INC., GLYSENS INCORPORATED, JOHNSON & JOHNSON, MANNKIND CORPORATION, MEDTRONIC PLC., NOVO NORDISK A/S, SANOFI, SENSEONICS HOLDINGS, INC. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Demographics (2021)
    Revenue Share (%), By Demographics (2021)
  • Revenue Share (%), By Indication (2021)
    Revenue Share (%), By Indication (2021)
  • Revenue Share (%), By End User (2021)
    Revenue Share (%), By End User (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Demographics

  • ADULT POPULATION (>14YEARS) accounted for US$28.37 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • CHILD POPULATION (≤14YEARS) accounted for US$0.77 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By Demographics 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By Demographics 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Size, By Demographics, 2019-2027 (USD billion)
Next Generation Diabetes Therapy and Drug Delivery Market Size, By Demographics, 2019-2027 (USD billion)

The ADULT POPULATION (>14YEARS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ADULT POPULATION (>14YEARS): global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
ADULT POPULATION (>14YEARS): global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)

The CHILD POPULATION (≤14YEARS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

CHILD POPULATION (≤14YEARS): global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
CHILD POPULATION (≤14YEARS): global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
04

By Indication

  • TYPE I DIABETES accounted for US$18.02 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • TYPE II DIABETES accounted for US$11.13 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By Indication 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By Indication 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Size, By Indication, 2019-2027 (USD billion)
Next Generation Diabetes Therapy and Drug Delivery Market Size, By Indication, 2019-2027 (USD billion)

The TYPE I DIABETES segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

TYPE I DIABETES: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
TYPE I DIABETES: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)

The TYPE II DIABETES segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

TYPE II DIABETES: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
TYPE II DIABETES: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
05

By End User

  • DIAGNOSTICS/CLINICS accounted for US$13.03 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • ICUS accounted for US$9.89 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • HOME HEALTHCARE accounted for US$6.23 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By End User 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Y-o-Y Growth (USD billion), By End User 2019 - 2027
Next Generation Diabetes Therapy and Drug Delivery Market Size, By End User, 2019-2027 (USD billion)
Next Generation Diabetes Therapy and Drug Delivery Market Size, By End User, 2019-2027 (USD billion)

The DIAGNOSTICS/CLINICS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

DIAGNOSTICS/CLINICS: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
DIAGNOSTICS/CLINICS: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)

The HOME HEALTHCARE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

HOME HEALTHCARE: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
HOME HEALTHCARE: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)

The ICUS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ICUS: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
ICUS: global Next Generation Diabetes Therapy and Drug Delivery Market Revenue Opportunity (Us$ Mn)
06

North America

  • In 2021, North America segment accounted for US$29.14 Bn and is expected grow with a CAGR of 9.15% over the forecast years.
  • In North America, United States accounted for US$25.75 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$3.39 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
North America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
North America Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Demographics - North America (2021)
Revenue Share (%), By Demographics - North America (2021)
Revenue Share (%), By Indication - North America (2021)
Revenue Share (%), By Indication - North America (2021)
Revenue Share (%), By End User - North America (2021)
Revenue Share (%), By End User - North America (2021)
North America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
North America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United States Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Canada Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
07

Europe

  • In 2021, Europe segment accounted for US$29.14 Bn and is expected grow with a CAGR of 9.15% over the forecast years.
  • In Europe, Germany accounted for US$11.68 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$7.49 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$4.69 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$2.71 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$1.54 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$1.02 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.01 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Europe Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Europe Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Demographics - Europe (2021)
Revenue Share (%), By Demographics - Europe (2021)
Revenue Share (%), By Indication - Europe (2021)
Revenue Share (%), By Indication - Europe (2021)
Revenue Share (%), By End User - Europe (2021)
Revenue Share (%), By End User - Europe (2021)
Europe Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Europe Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Germany Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
France Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Spain Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Russia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Italy Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Europe Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
08

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$29.14 Bn and is expected grow with a CAGR of 9.15% over the forecast years.
  • In Asia-Pacific, China accounted for US$11.17 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$7.05 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$5.42 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$3.17 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$1.69 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.64 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Demographics - Asia-Pacific (2021)
Revenue Share (%), By Demographics - Asia-Pacific (2021)
Revenue Share (%), By Indication - Asia-Pacific (2021)
Revenue Share (%), By Indication - Asia-Pacific (2021)
Revenue Share (%), By End User - Asia-Pacific (2021)
Revenue Share (%), By End User - Asia-Pacific (2021)
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
China Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Japan Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
India Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Australia & New Zealand Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
09

Middle East & Africa

Based on the Middle East & Africa, the Next Generation Diabetes Therapy and Drug Delivery Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Size, 2019-2027 (Us$ Mn)
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
10

Latin America

  • In 2021, Latin America segment accounted for US$29.14 Bn and is expected grow with a CAGR of 9.15% over the forecast years.
  • In Latin America, Brazil accounted for US$12.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$8.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$6.12 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$1.70 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$0.34 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Latin America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Demographics - Latin America (2021)
Revenue Share (%), By Demographics - Latin America (2021)
Revenue Share (%), By Indication - Latin America (2021)
Revenue Share (%), By Indication - Latin America (2021)
Revenue Share (%), By End User - Latin America (2021)
Revenue Share (%), By End User - Latin America (2021)
Latin America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Latin America Next Generation Diabetes Therapy and Drug Delivery Market, By Country, 2019-2027 (USD billion)
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Brazil Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Argentina Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Mexico Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Colombia Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Demographics, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By Indication, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Latin America Next Generation Diabetes Therapy and Drug Delivery Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
11

Company Analysis

  • ABBOTT LABORATORIES
  • DEXCOM, INC.
  • ECHO THERAPEUTICS, INC.
  • GLYSENS INCORPORATED
  • JOHNSON & JOHNSON
  • MANNKIND CORPORATION
  • MEDTRONIC PLC.
  • NOVO NORDISK A/S
  • SANOFI
  • SENSEONICS HOLDINGS, INC.